As Coronavirus Cases Spike, Vaccine News Offers Hope
Biotechnology company Moderna announced Monday that its coronavirus vaccine candidate appears to be 94.5% effective against the disease. The news comes one week after Pfizer announced that its vaccine was more than 90% effective in a clinical trial. As California rolls back reopening plans amid a spike in cases, we’ll discuss next steps for the new vaccines and what we know about safety and long-term effectiveness. Learn more about your ad choices. Visit megaphone.fm/adchoices
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.